7Baggers
 Synlogic files $150M mixed securities shelf  MSN Thu, 02 Oct 2025 04:04:40 GMT
 We Think Synlogic (NASDAQ:SYBX) Can Afford To Drive Business Growth  Yahoo Finance Thu, 18 Sep 2025 07:00:00 GMT
 short interest in synlogic, inc. (nasdaq:sybx) decreases by 27.9%  Defense World Tue, 16 Sep 2025 05:57:36 GMT
 published on: 2025-09-13 21:10:29  newser.com Sun, 14 Sep 2025 02:10:29 GMT
 published on: 2025-09-10 23:44:06  Newser Thu, 11 Sep 2025 04:44:06 GMT
 published on: 2025-09-05 06:05:47  Newser Fri, 05 Sep 2025 11:05:47 GMT
 published on: 2025-09-04 08:24:15  Newser Thu, 04 Sep 2025 13:24:15 GMT

Synlogic, Inc
(NASDAQ:SYBX) 

SYBX stock logo

Synlogic, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of synthetic biotic medicines to treat metabolic, inflammatory, and cancer diseases in the United States. Its therapeutic programs include SYNB1618, an oral therapy that is in Phase II clinical trial...

Founded: 2014
Full Time Employees: 76
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends